Business Context and Reporting Period
This Form 8-K is a current report filed by Coherus BioSciences, Inc. (CHRS) on October 13, 2021, regarding events occurring on October 8, 2021. The filing addresses a significant corporate governance event rather than routine financial reporting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is not a financial statement and contains no quantitative financial data.
Material Changes
The primary material change reported is the unexpected passing of Alan C. Mendelson, a member of the Company's Board of Directors, on October 8, 2021. The Company issued a press release (Exhibit 99.1) to honor his service since the company's founding.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, or specific business risks. The document focuses solely on the departure of a director due to death and the attachment of a commemorative press release.
Investor Verification Checklist
- Verify the status of the Board of Directors and any plans to fill the vacancy left by Mr. Mendelson.
- Review the attached press release (Exhibit 99.1) for details on Mr. Mendelson's tenure and contributions.
- Check subsequent filings for any impact on corporate governance or strategic direction resulting from this loss.